Human Bird Flu Cases Spur Retail Trader Rush Into Vaccine Stocks [BNN Bloomberg (Canada)]
Novavax, Inc. (NVAX)
Last novavax, inc. earnings: 3/11 04:17 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.novavax.com/investor-relations
Company Research
Source: BNN Bloomberg
Shares of CureVac NV, which has a bird-flu vaccine in early-stage testing, jumped 15% Wednesday as concerns grow over a potential outbreak of bird flu in humans following reports of a new case in Australia. Novavax Inc. — which recently touted its plans to explore an avian flu vaccine — gained for the third day closing at its highest level since December 2022. The shares of Covid shotmakers Moderna Inc. and BioNTech SE notched double-digit advances while Pfizer Inc. rose 3.7%. Read more: Just One Human Is Infected by Bird Flu. More US Cases Likely “Bird flu is adding momentum to stocks that were already going higher,” Jared Holz, a health-care specialist at Mizuho said. “A lot of it is probably just big picture — more retail-oriented trading on the back of these headlines linking the problems that are arising with bird flu with the vaccine stocks.” Past outbreaks like Ebola, Zika and monkey pox have spurred similar swings — particularly for smaller players — as companies come
Show less
Read more
Impact Snapshot
Event Time:
NVAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVAX alerts
High impacting Novavax, Inc. news events
Weekly update
A roundup of the hottest topics
NVAX
News
- Novavax Submits Application to U.S. FDA for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine [Yahoo! Finance]Yahoo! Finance
- Novavax Submits Application to U.S. FDA for Updated Protein-based 2024-2025 Formula COVID-19 VaccinePR Newswire
- Novavax, Inc. (NASDAQ: NVAX) had its price target raised by analysts at Bank of America Co. from $12.00 to $18.00. They now have a "neutral" rating on the stock.MarketBeat
- Bull Market and Beyond: 3 Stocks Just Waiting to Soar [Yahoo! Finance]Yahoo! Finance
- Novavax, Inc. (NASDAQ:NVAX) has caught the attention of institutional investors who hold a sizeable 49% stake [Yahoo! Finance]Yahoo! Finance
NVAX
Earnings
- 2/28/24 - Miss
NVAX
Analyst Actions
- 5/13/24 - HC Wainwright
NVAX
Sec Filings
- 6/14/24 - Form 4
- 6/14/24 - Form 4
- 6/14/24 - Form 4
- NVAX's page on the SEC website